Detalhe da pesquisa
1.
A global action agenda for turning the tide on fatty liver disease.
Hepatology
; 79(2): 502-523, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37540183
2.
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
J Hepatol
; 80(5): 694-701, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38286339
3.
Assessment of fatigue and its impact in chronic liver disease.
J Hepatol
; 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38670320
4.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37984709
5.
The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes.
Clin Gastroenterol Hepatol
; 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38521116
6.
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
Am J Gastroenterol
; 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38477467
7.
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials.
J Intern Med
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38738988
8.
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States.
J Viral Hepat
; 31(4): 181-188, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38158773
9.
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
J Viral Hepat
; 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38622910
10.
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
Hepatology
; 77(4): 1335-1347, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36626630
11.
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa.
Liver Int
; 44(4): 1061-1070, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38305642
12.
Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action.
Diabetes Spectr
; 37(1): 9-19, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38385101
13.
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Gut
; 72(3): 581-589, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36750244
14.
How to Identify Advanced Nonalcoholic Fatty Liver Disease in the Primary Care Setting.
Semin Liver Dis
; 43(2): 142-148, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37414024
15.
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties.
J Hepatol
; 79(1): 209-217, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36740046
16.
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
J Hepatol
; 78(2): 247-259, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36375686
17.
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
J Hepatol
; 79(5): 1110-1120, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37517454
18.
A global research priority agenda to advance public health responses to fatty liver disease.
J Hepatol
; 79(3): 618-634, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37353401
19.
The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression.
Clin Gastroenterol Hepatol
; 21(4): 970-977.e1, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35533993
20.
The Global Burden of Liver Disease.
Clin Gastroenterol Hepatol
; 21(8): 1978-1991, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37121527